BNGO
Bionano Genomics·NASDAQ
--
--(--)
--
--(--)
6.03 / 10
Outperform
Fund flow data show a good score (7.43/10) with overall inflow ratio of 0.456, indicating robust buying pressure across block, small, medium, large, and extra-large sizes. However, the trend is negative, suggesting price may still face selling pressure. Analyst consensus is overwhelmingly bullish (Strong Buy 100%), but with only one active analyst. This combination of positive sentiment and fund inflows partially offsets the weak fundamentals and technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-24
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate66.7%
Is money flowing into or out of BNGO?
- BNGO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.03/10 (Outperform).
